PFE Pfizer PE ratio, current and historical analysis
The current PE ratio of PFE cannot be calculated, as the latest EPS of -$0.45 is negative. Pfizer's last PE ratio on record was 75.76 in December 2023.
PFE PE ratio history
The mean historical PE ratio of Pfizer over the last ten years is 19.6. Looking back at the last ten years, PFE's PE ratio peaked in the Dec 2023 quarter at 75.76, with a price of $28.79 and an EPS of $0.38. The Apr 2023 quarter marked the lowest point at 7.89, with a price of $40.8 and an EPS of $5.17.
Pfizer PE ratio by year
Maximum annual increase: 726.17% in 2023
Maximum annual decrease: -63.13% in 2017
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 75.76 | 726.17% |
| 2022 | 9.17 | -39.11% |
| 2021 | 15.06 | -32.5% |
| 2020 | 22.31 | 64.04% |
| 2019 | 13.6 | -40.79% |
| 2018 | 22.97 | 126.31% |
| 2017 | 10.15 | -63.13% |
| 2016 | 27.53 | -3.64% |
| 2015 | 28.57 | 32.09% |
| 2014 | 21.63 | 128.16% |
PFE average PE ratio chart
PFE PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.79 | $395.7B |
| NVS Novartis AG | 14.77 | $238.01B |
| MRK Merck & Co Inc | 21.78 | $298.7B |
| ABT Abbott Laboratories | 35.81 | $198.1B |
| AZN Astrazeneca plc | 39.93 | $257.46B |
| AMGN Amgen Inc | 54.8 | $172.25B |
| LLY ELI LILLY & Co | 110.76 | $857.96B |
| BMY Bristol Myers Squibb Co | N/A | $98.73B |
| PFE Pfizer Inc | N/A | $161.84B |
Frequently asked questions
What is Pfizer's PE ratio?
The current price to earnings ratio of PFE cannot be determined, as its EPS of -$0.45 is negative.
What is the 3-year average PE ratio for Pfizer (PFE)?
The average PE ratio for PFE stock over the past 3 years is 17.77.
What is the 5-year average PE ratio for Pfizer (PFE)?
The average PE ratio for PFE stock over the past 5 years is 17.35.
What is the highest PE ratio for PFE?
Over the last ten years, the quarterly PE ratio reached its highest level at 75.76 in the Dec 2023 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.